- Home
- Applications
- north america
- tumor mutation
Refine by
Tumor Mutation Product Applications In North America
1 applications found
Unfortunately, this benefit does not extend to patients whose tumors contain mutations in EGFR signaling components KRAS and BRAF, which together represent 50% of all colorectal cancers. ...
ByBiocept based in San Diego, CALIFORNIA (USA)